Eupraxia Pharmaceuticals (EPRX) Return on Equity (ROE) (2022 - 2025)
Eupraxia Pharmaceuticals (EPRX) Return on Equity (ROE) from Dec 31, 2022 to Dec 31, 2025. The TTM Eupraxia Pharmaceuticals (EPRX) Return on Equity (ROE) is -54.50%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROE
Annual Return on Equity (ROE) change of Eupraxia Pharmaceuticals (EPRX)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2025 | -47.03% | -38.41% |
| 2024 | -76.35% | -93.99% |
| 2023 | -1271.17% | +435.56% |
| 2022 | -237.36% | N/A |